![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Howard Hughes Medical Institute, Department of Cardiology, Children's Hospital, Boston, Massachusetts.
Abstract
We have used exons 2 and 3 of the rat alpha-tropomyosin gene to analyze the basis of mutually exclusive exon selection. The basis of the strict mutually exclusive behavior of this exon pair is enforced by the proximity of the exon 3 branchpoint to the 5' splice site of exon 2. With the exception of smooth muscle cells, exon 3 rather than exon 2 is incorporated into mRNA in all cell types. We show here, using both in vivo and in vitro cell-free systems, that this alternative exon selection is a consequence of general principles that govern 3' splice site selection. In the absence of exon 3, exon 2 is utilized efficiently in all cells. Selection of exon 3 is therefore the default result of a competition between exons 2 and 3 for the flanking constitutive splice sites. The basis of this competition is the relative strength of the polypyrimidine tract/branchpoint elements of the two exons. The major determinant of this splice site strength is the pyrimidine content adjacent to the branchpoint, and this involves no other sequence specificity. The branchpoint elements play an important but secondary role. The functional strengths of the different polypyrimidine tract/branchpoint combinations, as determined in cis competition assays, showed a perfect correlation with their binding affinities to a spliceosome component that interacts with the pre-mRNA in an ATP-independent manner. Selection of exon 3 in most cell types therefore reflects the preferential interaction of these splice site elements with constitutive splicing factors early in spliceosome assembly. The aspects of splice site selection analyzed here are likely to be of general applicability to constitutive and alternative pre-mRNA splicing.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Gunning, G. O'neill, and E. Hardeman Tropomyosin-Based Regulation of the Actin Cytoskeleton in Time and Space Physiol Rev, January 1, 2008; 88(1): 1 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Crawford and J. G. Patton Activation of {alpha}-Tropomyosin Exon 2 Is Regulated by the SR Protein 9G8 and Heterogeneous Nuclear Ribonucleoproteins H and F Mol. Cell. Biol., December 1, 2006; 26(23): 8791 - 8802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Arrisi-Mercado, M. Romano, A. F. Muro, and F. E. Baralle An Exonic Splicing Enhancer Offsets the Atypical GU-rich 3' Splice Site of Human Apolipoprotein A-II Exon 3 J. Biol. Chem., September 17, 2004; 279(38): 39331 - 39339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Ellis, C. W. J. Smith, and P. Kemp Regulated Tissue-specific Alternative Splicing of Enhanced Green Fluorescent Protein Transgenes Conferred by {alpha}-Tropomyosin Regulatory Elements in Transgenic Mice J. Biol. Chem., August 27, 2004; 279(35): 36660 - 36669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Gromak and C. W. J. Smith A splicing silencer that regulates smooth muscle specific alternative splicing is active in multiple cell types Nucleic Acids Res., August 15, 2002; 30(16): 3548 - 3557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Expert-Bezancon, J. P. Le Caer, and J. Marie Heterogeneous Nuclear Ribonucleoprotein (hnRNP) K Is a Component of an Intronic Splicing Enhancer Complex That Activates the Splicing of the Alternative Exon 6A from Chicken beta -Tropomyosin Pre-mRNA J. Biol. Chem., May 3, 2002; 277(19): 16614 - 16623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Standiford, W. T. Sun, M. B. Davis, and C. P. Emerson , Jr. Positive and Negative Intronic Regulatory Elements Control Muscle-Specific Alternative Exon Splicing of Drosophila Myosin Heavy Chain Transcripts Genetics, January 1, 2001; 157(1): 259 - 271. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z.-M. Zheng, J. Quintero, E. S. Reid, C. Gocke, and C. C. Baker Optimization of a Weak 3' Splice Site Counteracts the Function of a Bovine Papillomavirus Type 1 Exonic Splicing Suppressor In Vitro and In Vivo J. Virol., July 1, 2000; 74(13): 5902 - 5910. [Abstract] [Full Text]
|
|
|
|
|
|
C. Bergsdorf, K. Paliga, S. Kreger, C. L. Masters, and K. Beyreuther Identification of cis-Elements Regulating Exon 15 Splicing of the Amyloid Precursor Protein Pre-mRNA J. Biol. Chem., January 21, 2000; 275(3): 2046 - 2056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Southby, C. Gooding, and C. W. J. Smith Polypyrimidine Tract Binding Protein Functions as a Repressor To Regulate Alternative Splicing of alpha -Actinin Mutally Exclusive Exons Mol. Cell. Biol., April 1, 1999; 19(4): 2699 - 2711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lou, D. M. Helfman, R. F. Gagel, and S. M. Berget Polypyrimidine Tract-Binding Protein Positively Regulates Inclusion of an Alternative 3'-Terminal Exon Mol. Cell. Biol., January 1, 1999; 19(1): 78 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Davis, J. Dietz, D. M. Standiford, and C. P. Emerson , Jr. Transposable Element Insertions Respecify Alternative Exon Splicing in Three Drosophila Myosin Heavy Chain Mutants Genetics, November 1, 1998; 150(3): 1105 - 1114. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. A. Doevendans, P. Ruiz-Lozano, and M. van Bilsen Hunting down nucleic acid binding factors in the cardiovascular system Cardiovasc Res, May 1, 1998; 38(2): 301 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Carstens, W. L. McKeehan, and M. A. Garcia-Blanco An Intronic Sequence Element Mediates Both Activation and Repression of Rat Fibroblast Growth Factor Receptor 2 Pre-mRNA Splicing Mol. Cell. Biol., April 1, 1998; 18(4): 2205 - 2217. [Abstract] [Full Text]
|
|
|
|
|
|
K. Kashiwada, W. Nishida, K.'i. Hayashi, K. Ozawa, Y. Yamanaka, H. Saga, T. Yamashita, M. Tohyama, S. Shimada, K. Sato, et al. Coordinate Expression of alpha -Tropomyosin and Caldesmon Isoforms in Association with Phenotypic Modulation of Smooth Muscle Cells J. Biol. Chem., June 13, 1997; 272(24): 15396 - 15404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Dietrich-Goetz, I. M. Kennedy, B. Levins, M. A. Stanley, and J. B. Clements A cellular 65-kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA PNAS, January 7, 1997; 94(1): 163 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Singh, J Valcarcel, and M. Green Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins Science, May 26, 1995; 268(5214): 1173 - 1176. [Abstract] [PDF]
|
|
|
|
 |
|
 J Vilardell and J R Warner Regulation of splicing at an intermediate step in the formation of the spliceosome. Genes & Dev., January 15, 1994; 8(2): 211 - 220. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Norton Alternative pre-mRNA splicing: factors involved in splice site selection J. Cell Sci., January 1, 1994; 107(1): 1 - 7. [PDF]
|
|
|
|
|
|
S Michaud and R Reed A functional association between the 5' and 3' splice site is established in the earliest prespliceosome complex (E) in mammals. Genes & Dev., June 1, 1993; 7(6): 1008 - 1020. [Abstract] [PDF]
|
|
|
|
|
|
J G Patton, E B Porro, J Galceran, P Tempst, and B Nadal-Ginard Cloning and characterization of PSF, a novel pre-mRNA splicing factor. Genes & Dev., March 1, 1993; 7(3): 393 - 406. [Abstract] [PDF]
|
|
|
|
|
|
B E Hoffman and P J Grabowski U1 snRNP targets an essential splicing factor, U2AF65, to the 3' splice site by a network of interactions spanning the exon. Genes & Dev., December 1, 1992; 6(12b): 2554 - 2568. [Abstract] [PDF]
|
|
|
|
|
|
H. J. Mardon and G. Sebastio Regulation of alternative splicing in the IIICS region of human fibronectin pre-mRNA encoding cell binding sites CS1 and CS5 J. Cell Sci., October 1, 1992; 103(2): 423 - 433. [Abstract] [PDF]
|
|
|
|
|
|
L C Ryner and B S Baker Regulation of doublesex pre-mRNA processing occurs by 3'-splice site activation. Genes & Dev., November 1, 1991; 5(11): 2071 - 2085. [Abstract] [PDF]
|
|
|
|
|
|
W Guo, G J Mulligan, S Wormsley, and D M Helfman Alternative splicing of beta-tropomyosin pre-mRNA: cis-acting elements and cellular factors that block the use of a skeletal muscle exon in nonmuscle cells. Genes & Dev., November 1, 1991; 5(11): 2096 - 2107. [Abstract] [PDF]
|
|
|
|
|
|
J G Patton, S A Mayer, P Tempst, and B Nadal-Ginard Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing. Genes & Dev., July 1, 1991; 5(7): 1237 - 1251. [Abstract] [PDF]
|
|
